Pathways to personalized medicine—Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0.520. It has been cited 31 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.520
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P30 AG062421
NIA NIH HHS
Grant: P01 AG036694
National Institutes of Health
Grant: 1P30AG066512-01
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5P30AG062421-03
Massachusetts Alzheimer's Disease Research Center
National Institutes of Health
Grant: 3P01AG036694-09S2
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study
Challenger Foundation
MeSH Terms
Keywords